Ching-Shan Luo

409 total citations
8 papers, 296 citations indexed

About

Ching-Shan Luo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ching-Shan Luo has authored 8 papers receiving a total of 296 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Ching-Shan Luo's work include Lung Cancer Treatments and Mutations (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Lung Cancer Research Studies (2 papers). Ching-Shan Luo is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (2 papers) and Lung Cancer Research Studies (2 papers). Ching-Shan Luo collaborates with scholars based in Taiwan, Vietnam and Japan. Ching-Shan Luo's co-authors include Kuan-Yuan Chen, Po‐Hao Feng, Kang‐Yun Lee, Sheng‐Ming Wu, Nguyễn Văn Hiệp, Wei-Lun Sun, Chun‐Jen Liu, Wanli Cheng, Tzu-Tao Chen and Hsiao‐Chi Chuang and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Toxicology and Applied Pharmacology.

In The Last Decade

Ching-Shan Luo

8 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ching-Shan Luo Taiwan	5	125	124	84	56	51	8	296
N G Kastrinakis Greece	7	178 1.4×	98 0.8×	43 0.5×	57 1.0×	23 0.5×	7	354
Wan Mahadzir Wan Mustafa Malaysia	14	240 1.9×	124 1.0×	47 0.6×	93 1.7×	24 0.5×	22	416
Danielle MacNeil Canada	13	146 1.2×	112 0.9×	54 0.6×	67 1.2×	30 0.6×	34	357
Andrew Thomason United Kingdom	4	128 1.0×	152 1.2×	151 1.8×	16 0.3×	30 0.6×	7	369
Tanja K. Eggersmann Germany	8	50 0.4×	76 0.6×	66 0.8×	26 0.5×	43 0.8×	23	217
Gábor Pajkos Hungary	10	118 0.9×	191 1.5×	72 0.9×	81 1.4×	12 0.2×	17	318
Jayendra B. Patel India	12	195 1.6×	104 0.8×	20 0.2×	104 1.9×	36 0.7×	24	448
Hsiang‐Fong Kao Taiwan	8	126 1.0×	208 1.7×	108 1.3×	46 0.8×	59 1.2×	28	372
Lijuan Bian China	11	157 1.3×	52 0.4×	40 0.5×	130 2.3×	28 0.5×	19	311
Siang-Jyun Tu Taiwan	8	155 1.2×	38 0.3×	59 0.7×	119 2.1×	18 0.4×	14	233

Countries citing papers authored by Ching-Shan Luo

Since Specialization

Citations

This map shows the geographic impact of Ching-Shan Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching-Shan Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching-Shan Luo more than expected).

Fields of papers citing papers by Ching-Shan Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching-Shan Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching-Shan Luo. The network helps show where Ching-Shan Luo may publish in the future.

Co-authorship network of co-authors of Ching-Shan Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ching-Shan Luo. A scholar is included among the top collaborators of Ching-Shan Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching-Shan Luo. Ching-Shan Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Luo, Ching-Shan, et al.. (2025). Polycyclic aromatic hydrocarbon-aryl hydrocarbon receptor signaling regulates chronic inflammation in lung-gut axis. Toxicology and Applied Pharmacology. 500. 117359–117359. 2 indexed citations

Luo, Ching-Shan, et al.. (2024). Development and validation of a novel combinational index of liquid biopsy biomarker for longitudinal lung cancer patient management. SHILAP Revista de lepidopterología. 6. 100167–100167. 1 indexed citations

Chang, Chih‐Cheng, et al.. (2023). Targeting Lung–Gut Axis for Regulating Pollution Particle–Mediated Inflammation and Metabolic Disorders. Cells. 12(6). 901–901. 20 indexed citations

Hiệp, Nguyễn Văn, Wei-Lun Sun, Po‐Hao Feng, et al.. (2022). Heparin binding epidermal growth factor–like growth factor is a prognostic marker correlated with levels of macrophages infiltrated in lung adenocarcinoma. Frontiers in Oncology. 12. 963896–963896. 4 indexed citations

Chen, Kuan-Yuan, Kang‐Yun Lee, Albert Qin, et al.. (2021). Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan. Advances in Therapy. 39(2). 910–922. 6 indexed citations

Cheng, Wanli, Po‐Hao Feng, Kang‐Yun Lee, et al.. (2021). The Role of EREG/EGFR Pathway in Tumor Progression. International Journal of Molecular Sciences. 22(23). 12828–12828. 141 indexed citations

Feng, Po‐Hao, Kuan-Yuan Chen, Yu‐Chen Huang, et al.. (2018). Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma. Journal of Thoracic Oncology. 13(7). 958–967. 68 indexed citations

Luo, Ching-Shan, et al.. (2006). Human papillomaviruses in oral squamous cell carcinoma and pre-cancerous lesions detected by PCR-based gene-chip array. International Journal of Oral and Maxillofacial Surgery. 36(2). 153–158. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact